Dapagliflozin NDC 27241-151

NDC codes

FDA NDC Directory

Product NDC (as listed)27241-151Labeler and product segments. Claims need a package NDC.

Product NDC at billing width27241-0151Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
27241-151-01	27241015101	30 TABLET in 1 BOTTLE (27241-151-01)Marketed from Apr 6, 2026
27241-151-90	27241015190	90 TABLET in 1 BOTTLE (27241-151-90)Marketed from Sep 2, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Dapagliflozin
Generic name (nonproprietary): dapagliflozin
Active ingredients: Dapagliflozin — 5 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Ajanta Pharma USA Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 211482
Marketing start: Apr 6, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Sodium-Glucose Transporter 2 Inhibitors (Mechanism)
Identifiers: Product ID 27241-151_af7c3e48-a7c2-4f5a-b812-b0c089fa2a79SPL ID af7c3e48-a7c2-4f5a-b812-b0c089fa2a79
Pharmacologic class: Sodium-Glucose Cotransporter 2 Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N427241015101 followed by a unit qualifier and the quantity

Package 27241-0151-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

Other NDCs under ANDA 211482

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 211482
Product	Strength	Form · route	Labeler	Product NDC
Dapagliflozin	Dapagliflozin 10 mg/1	TabletOral	Ajanta Pharma USA Inc.	27241-152